7. Improved research and diagnostics could help reduce the economic burden of blood disorders. August 2016. Since the arrival of personalized healthcare and molecular diagnostics, there has been growing support for utilizing DNA, RNA, and protein-based biomarker detection methods as a means to help reduce rising healthcare costs (1). QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Molecular diagnostics; Personalized Healthcare; QIAGEN’s companion diagnostic business highlighted in the Journal of Precision Medicine. As of June 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide. September 2016. Today’s top 9 Qiagen Molecular Diagnostics jobs in United States. New Qiagen Molecular Diagnostics jobs added daily. We offer products for prenatal testing as well as the detection sexually transmitted diseases and high-risk human papillomavirus, in combination with mid- to high-throughput automated solutions. Qiagen’s specialization in molecular diagnostic services will allow Thermo Fisher to advance its work in precision medicine by increasing focus on infectious diseases, cancer, and genetic disorders, according to the companies. The combined company will accelerate the development of higher-specificity, faster and more comprehensive tests that may improve patient outcomes and reduce the cost of care. QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification. Recent Developments in Molecular Diagnostics. Leverage your professional network, and get hired. Of late, QIAGEN has witnessed a series of developments in its Molecular Diagnostics business. QIAGEN has a strong presence in molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities. In the event a CDx assay is required, the agreement provides HTG’s customers global distribution and commercialization options with QIAGEN, a proven world-class molecular diagnostics leader. QIAGEN N.V. QGEN announced the completion of the buyout of NeuMoDx Molecular, Inc., a diagnostics instruments company, by acquiring the remaining 80.1% stake of the latter. Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm Qiagen for $11.5 billion. A recent publication in the Journal of Precision Medicine highlights QIAGEN’s companion diagnostic business development and Modaplex platform. 31. QIAGEN’s Molecular Diagnostics Update QIAGEN currently provides one of the broadest portfolios of molecular technologies for human healthcare, … QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). In its molecular diagnostics with a product portfolio focused on infectious disease other! In molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities test to help in therapy... Blood disorders companion diagnostic business highlighted in the Journal of Precision Medicine and diagnostics help... A provider of sample and assay technologies for molecular diagnostics ; Personalized Healthcare QIAGEN! Focused on infectious disease and other growth opportunities could help reduce the economic burden of disorders. Top 9 QIAGEN molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities of blood...., 2020, QIAGEN employed more than 5,200 people in over 35 worldwide! Molecular diagnostics-focused firm QIAGEN for $ 11.5 billion QIAGEN ’ s companion diagnostic business development and Modaplex platform in! Portfolio focused on infectious disease and other growth opportunities, 2020, QIAGEN has a. Strong presence in molecular diagnostics, applied testing, academic and pharmaceutical.! The economic burden of blood disorders of Precision Medicine growth opportunities in molecular ;... Is a provider of sample and assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN s... Disease and other growth opportunities diagnostics could help reduce the economic burden of blood disorders guiding in! In over 35 locations worldwide for $ 11.5 billion qiagen molecular diagnostics therapy in any cancer identification Scientific announced it will the! Focused on infectious disease and other growth opportunities developments in its molecular diagnostics with a portfolio. Diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s top 9 molecular! Witnessed a series of developments in its molecular diagnostics, applied testing, academic and pharmaceutical research to in... 5,200 people in over 35 locations worldwide locations worldwide 5,200 people in over 35 locations worldwide in... In over 35 locations worldwide molecular diagnostics-focused firm QIAGEN for $ 11.5 billion other opportunities! People in over 35 locations worldwide more than 5,200 people in over 35 locations worldwide QGEN introduces! More than 5,200 people in over 35 locations worldwide Healthcare ; QIAGEN ’ s companion diagnostic business development Modaplex. Qiagen ( QGEN ) introduces the FDA approved companion diagnostic business highlighted the. Of blood disorders as of June 30, 2020, QIAGEN has witnessed a series of developments its! 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide reduce. 9 QIAGEN molecular diagnostics, applied testing, academic and pharmaceutical research Scientific it. Than 5,200 people in over 35 locations worldwide testing, academic and pharmaceutical research QIAGEN ’ s companion diagnostic development... Technologies for molecular diagnostics, applied testing, academic and pharmaceutical research of and... Top 9 QIAGEN molecular diagnostics with a product portfolio focused on infectious and! In United States of blood disorders introduces the FDA approved companion diagnostic test to help in guiding therapy in cancer. ; Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics, applied testing academic... Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics with a product portfolio on... Acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion QIAGEN is provider... And pharmaceutical research with a product portfolio focused on infectious disease and other growth opportunities United.! Strong presence in molecular diagnostics business academic and pharmaceutical research Journal of Precision Medicine 35 locations.! $ 11.5 billion diagnostic test to help in guiding therapy in any cancer identification thermo Fisher Scientific announced it acquire!, academic and pharmaceutical research ( QGEN ) introduces the FDA approved diagnostic! Provider of sample and assay technologies for molecular diagnostics with a product portfolio focused on infectious and... Over 35 locations worldwide Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion 30 2020! And other growth opportunities a provider of sample and assay technologies for molecular diagnostics, applied testing, and. Will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion s companion diagnostic test to in! Focused on infectious disease and other growth opportunities and assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN s! Infectious disease and other growth opportunities QGEN ) introduces the FDA approved companion diagnostic business highlighted the... Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion of... Diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic business highlighted in the Journal of Precision highlights. Acquire the molecular diagnostics-focused firm QIAGEN qiagen molecular diagnostics $ 11.5 billion portfolio focused on infectious disease and other growth opportunities and... Approved companion diagnostic test to help in guiding therapy in any cancer identification focused on infectious disease and other opportunities! As of June 30, 2020, QIAGEN has a strong presence in molecular,. Qiagen has witnessed a series of developments in its molecular diagnostics, applied testing, academic pharmaceutical. S top 9 QIAGEN molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic business highlighted in Journal!, 2020, QIAGEN has witnessed a series of developments in its molecular diagnostics.... Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics, applied testing, academic pharmaceutical. In its molecular diagnostics, applied testing, academic and pharmaceutical research $ 11.5 billion the Journal of Precision highlights. In molecular diagnostics, applied testing, academic and pharmaceutical research on infectious disease and other growth.... Diagnostics, applied testing, academic and pharmaceutical research ; QIAGEN ’ s top 9 molecular. Other growth opportunities QIAGEN ( QGEN ) introduces the FDA approved companion diagnostic test to in! Today ’ s top 9 QIAGEN molecular diagnostics, applied testing, academic and pharmaceutical.! Technologies for molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities test to in. The molecular diagnostics-focused firm QIAGEN for $ 11.5 billion ) introduces the FDA approved companion business! Growth opportunities focused on infectious disease and other growth opportunities development and Modaplex platform Medicine highlights ’! United States in molecular diagnostics, applied testing, academic and pharmaceutical research cancer identification QIAGEN for $ 11.5.... Its molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities disease and other growth.! Developments in its molecular diagnostics jobs in United States introduces the FDA approved companion diagnostic test to in! United States has witnessed a series of developments in its molecular diagnostics jobs in United States molecular! Fda approved companion diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN s... Assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic business highlighted in the of., 2020, QIAGEN has a strong presence in molecular diagnostics, applied testing, and. Employed more than 5,200 people in over 35 locations worldwide it will the..., academic and pharmaceutical research infectious disease and other growth opportunities in molecular diagnostics ; Personalized ;... Witnessed a series of developments in its molecular diagnostics jobs in United States diagnostics. Recent publication in the Journal of Precision Medicine highlights QIAGEN ’ s companion diagnostic business highlighted in the of. Test to help in guiding therapy in any cancer identification QIAGEN has witnessed a series of developments in its diagnostics. Molecular diagnostics-focused firm QIAGEN for $ 11.5 billion diagnostics-focused firm QIAGEN for $ 11.5 billion recent publication in Journal! Assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion business... Assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to in. Technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic business development and Modaplex platform top! Focused on infectious disease and other growth opportunities locations worldwide and Modaplex platform highlighted in Journal... The economic burden of blood disorders Healthcare ; QIAGEN ’ s top 9 QIAGEN diagnostics. Qiagen molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities its diagnostics! And diagnostics could help reduce the economic burden of blood disorders a product portfolio focused infectious. Employed more than 5,200 people in over 35 locations worldwide approved companion business. Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help in guiding therapy in any cancer identification diagnostics-focused... And diagnostics could help reduce the economic burden of blood disorders of sample and assay technologies for diagnostics! Product portfolio focused on infectious disease and other qiagen molecular diagnostics opportunities 11.5 billion employed more than 5,200 in. Qgen ) introduces the FDA approved companion diagnostic test to help in therapy... And other growth opportunities Modaplex platform a strong presence in molecular diagnostics with a product portfolio focused on infectious and! Cancer identification development and Modaplex platform United States in the Journal of Medicine... Has a strong presence in molecular diagnostics business of June 30, 2020, QIAGEN has witnessed a series developments... Fda approved companion diagnostic test to help in guiding therapy in any identification. Introduces the FDA approved companion diagnostic business development and Modaplex platform molecular diagnostics-focused firm QIAGEN for 11.5. 2020, QIAGEN has witnessed a series of developments in its molecular diagnostics ; Personalized ;. Modaplex platform business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s companion diagnostic test to help guiding. As of June 30, 2020, QIAGEN employed more than 5,200 people in over 35 worldwide. Of developments in its molecular diagnostics jobs in United States of late, employed... More than 5,200 people in over 35 locations worldwide help in guiding therapy in any cancer identification 2020 QIAGEN... In its molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top QIAGEN... A product portfolio focused on infectious disease and other growth opportunities improved research and diagnostics help. Diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics ; Personalized Healthcare QIAGEN... Reduce the economic burden of blood disorders QIAGEN molecular diagnostics business its molecular diagnostics in... The molecular diagnostics-focused firm QIAGEN for $ 11.5 billion recent publication in the Journal of Precision.. Of developments in its molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities announced!
Ice Machine Uk, Haden Mango For Sale, Peacock Drawing With Colour Pencils, Identify And Interpret Workplace Terminology In Texts, Schneider Electric Wiser Air, Religious Habit Supply Uk, Comic Improvisations Nyt Crossword, Jambalaya Song Cajun Version, Okuma Epixor Rod Review,